Νοέ32015Βιβλιογραφικά δεδομέναΓια να δείτε το άρθρο πιέστε εδώ Κατηγορία Βιβλιογραφικά δεδομένα3 Νοεμβρίου 2015 Μοιραστείτε το! Share on FacebookShare on Facebook Share on XShare on X Share on LinkedInShare on LinkedIn Share on WhatsAppShare on WhatsApp Post navigationΠροηγούμενοPrevious post:Improvement of liver function parameters in advanced HCV-associated liver cirrhosis by IFN-free antiviral therapiesΕπόμενοNext post:Σύνοψη AASLD 2015Σχετικά ΆρθραPrognostic implications of recompensation of decompensated cirrhosis after SVR in patients with hepatitis C6 Νοεμβρίου 2025Meta- Analysis: Comparison of Living Versus Deceased Liver Transplantation for Primary Sclerosing Cholangitis4 Νοεμβρίου 2025Development and validation of a risk prediction model for patients with hepatocellular carcinoma receiving atezolizumab-bevacizumab27 Οκτωβρίου 2025Noninvasive Assessment of Portal Hypertension in Patients With Primary Biliary Cholangitis Is Affected by Severity of Cholestasis27 Οκτωβρίου 2025Phosphatidylethanol and self-reported alcohol intake to subclassify individuals at risk of steatotic liver disease: an analysis of data from a prospective cohort study23 Οκτωβρίου 2025Risk of de novo HCC in patients with MASLD following direct acting antiviral-induced cure of HCV infection23 Οκτωβρίου 2025
Prognostic implications of recompensation of decompensated cirrhosis after SVR in patients with hepatitis C6 Νοεμβρίου 2025
Meta- Analysis: Comparison of Living Versus Deceased Liver Transplantation for Primary Sclerosing Cholangitis4 Νοεμβρίου 2025
Development and validation of a risk prediction model for patients with hepatocellular carcinoma receiving atezolizumab-bevacizumab27 Οκτωβρίου 2025
Noninvasive Assessment of Portal Hypertension in Patients With Primary Biliary Cholangitis Is Affected by Severity of Cholestasis27 Οκτωβρίου 2025
Phosphatidylethanol and self-reported alcohol intake to subclassify individuals at risk of steatotic liver disease: an analysis of data from a prospective cohort study23 Οκτωβρίου 2025
Risk of de novo HCC in patients with MASLD following direct acting antiviral-induced cure of HCV infection23 Οκτωβρίου 2025
